4//SEC Filing
Autor Deborah M. 4
Accession 0001628280-24-024342
CIK 0001723128other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:10 PM ET
Size
7.2 KB
Accession
0001628280-24-024342
Insider Transaction Report
Form 4
Autor Deborah M.
Director
Transactions
- Sale
Class A Common Stock
2024-05-17$6.73/sh−23,447$157,728→ 93,402 total - Sale
Class A Common Stock
2024-05-16$6.76/sh−14,553$98,378→ 116,849 total
Footnotes (3)
- [F1]The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.79 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.70 to $6.77 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001884671
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:10 PM ET
- Size
- 7.2 KB